Stay updated on Covalent Menin Inhibitor BMF-219 Clinical Trial
Sign up to get notified when there's something new on the Covalent Menin Inhibitor BMF-219 Clinical Trial page.

Latest updates to the Covalent Menin Inhibitor BMF-219 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page indicates that Biomea Fusion, Inc. has terminated its pursuit of oncology indications for BMF-219, and some NLM-NCBI services are experiencing heavy traffic, which may affect performance. Additionally, a date of 2025-02-07 has been added.SummaryDifference10%
- Check39 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check54 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check61 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check90 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Covalent Menin Inhibitor BMF-219 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Covalent Menin Inhibitor BMF-219 Clinical Trial page.